Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 314

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

Open access
Tatarczyńska, Ewa, Kłodzińska, Aleksandra, Chojnacka‐Wójcik, Ewa, Pałucha, Agnieszka, Gasparini, Fabrizio, Kuhn, Rainer, Pilc, Andrzej·2001·British Journal of Pharmacology

Abstract

Several lines of evidence suggest a crucial involvement of glutamate in the mechanism of action of anxiolytic and/or antidepressant drugs. The involvement of group I mGlu receptors in anxiety and depression has also been proposed. Given the recent discovery of a selective and brain penetrable mGlu5 receptor antagonists, the effect of 2‐methyl‐6‐(phenylethynyl)‐pyridine (MPEP), i.e. the most potent compound described, was evaluated in established models of anxiety and depression. Experiments were performed on male Wistar rats or male Albino Swiss or C57BL/6J mice. The anxiolytic‐like effects of MPEP was tested in the conflict drinking test and the elevated plus‐maze test in rats as well as in the four‐plate test in mice. The antidepressant‐like effect was estimated using the tail suspension test in mice and the behavioural despair test in rats. MPEP (1 – 30 mg kg−1) induced anxiolytic‐like effects in the conflict drinking test and the elevated plus‐maze test in rats as well as in the four‐plate test in mice. MPEP had no effect on locomotor activity or motor coordination. MPEP (1 – 20 mg kg−1) did shorten the immobility time in a tail suspension test in mice, however it was inactive in the behavioural despair test in rats. These data suggest that selective mGlu5 receptor antagonists may play a role in the therapy of anxiety and/or depression, further studies are required to identify the sites and the mechanism of action of MPEP. British Journal of Pharmacology (2001) 132, 1423–1430; doi:10.1038/sj.bjp.0703923

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0703923

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 314

Metadata

Authors
Tatarczyńska, E., Kłodzińska, A., Chojnacka‐Wójcik, E., Pałucha, A., Gasparini, F., Kuhn, R., & Pilc, A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2001-04
Volume
132
Issue
7
Pages
1423-1430
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1978157729
Cited by
314
References
38
FWCI
12.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. https://app.cochat.ai/papers/10.1038/sj.bjp.0703923
The paper
Tatarczyńska, E., Kłodzińska, A., Chojnacka‐Wójcik, E., Pałucha, A., Gasparini, F., Kuhn, R., & Pilc, A. (2001). Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0703923

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.